Alanine scanning of all cysteines and construction of a functional cysteine-less Cdr1p, a multidrug ABC transporter of Candida albicans

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 508-513

  Prasad, Rajendra ^a   Shah, Abdul Haseeb ^a   Sanwal, Hina ^a   Kapoor, Khyati ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

ABC transporter; Candida albicans; Cdr1p; Cysless Cdr1p; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ALANINE; ANISOMYCIN; CDR1P PROTEIN; CYCLOHEXIMIDE; CYSTEINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; RHODAMINE 6G; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; YEAST;

ALANINE; AMINO ACID SUBSTITUTION; ATP-BINDING CASSETTE TRANSPORTERS; CANDIDA ALBICANS; CROSS-LINKING REAGENTS; CYSTEINE; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTAGENESIS, SITE-DIRECTED;

CANDIDA ALBICANS;

EID: 84855800113     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.150     Document Type: Article

References (21)

1. Prasad R., Wergifosse P.D., Goffeau A., Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 1995, 27:320-329.
2. Sanglard D., Ischer F., Monod M., Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterisation of CDR2, a new multidrug ABC transporter gene. Microbiology 1997, 143:405-416.
3. Fling M.E., Kopf J., Tamarkin A., Gorman J.A., Smith H.A., Koltin Y. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 1991, 227:318-329.
4. Albertson G.D., Niimi M., Cannon R.D., Jenkinson H.F. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 1996, 40:2835-2841.
5. Nakamura K., Niimi M., Niimi K., Holmes A.R., Yates J.E., Decottignies A., Monk B.C., Goffeau A., Cannon R.D. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 2001, 45:3366-3374.
6. Prasad R., Snehlata P., Smriti Drug resistance in yeasts - an emerging scenario. Adv. Microb. Physiol. 2002, 46:155-201.
7. Saini P., Prasad T., Gaur N.A., Shukla S., Jha S., Komath S.S., Khan L.A., Haq Q.M., Prasad R. Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. J. Antimicrob. Chemother. 2005, 56:77-86.
8. Shukla S., Saini P., Smriti, Jha S., Ambudkar S.V., Prasad R. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell 2003, 2:1361-1375.
9. Prasad R., Kapoor K. Multidrug resistance in yeast, Candida. Int. Rev. Cytol. 2005, 242:215-248.
10. Loo T.W., Clarke D.M. Determining the structure and mechanism of the human multidrug resistance P-glycoprotein using cysteine-scanning mutagenesis and thiol-modification techniques. Biochim. Biophys. Acta 1999, 1461:315-325.
11. Chen E.Y., Bartlett M.C., Loo T.W., Clarke D.M. The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 2004, 279:39620-39627.
12. Loo T.W., Clarke D.M. Location of the rhodamine-binding site in the human multidrug-resistance P-glycoprotein. J. Biol. Chem. 2002, 277:44332-44338.
13. Loo T.W., Bartlett M.C., Clarke D.M. Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR). J. Biol. Chem. 2008, 283:28190-28197.
14. Loo T.W., Clarke D.M. Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers. J. Biol. Chem. 2001, 276:36877-36880.
15. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., Harrell P.M., Trinh Y.T., Zhang Q., Urbatsch I.L., Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009, 323:1718-1722.
16. Pagant S., Brovman E.Y., Halliday J.J., Miller E.A. Mapping of inter-domain interfaces required for the functional architecture of Yor1p, a eukaryotic ABC transporter. J. Biol. Chem. 2008, 283:26444-26451.
17. Mukhopadhyay K., Kohli A., Prasad R. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 2002, 46:3695-3705.
18. Decottignies A., Grant A.M., Nichols J.W., Wet H., McIntosh D.B., Goffeau A. ATPase and multidrug transport activities of the overexpressed yeast ABC potein Yor1p. J. Biol. Chem. 1998, 273:12612-12622.
19. Jha S., Neerja K., Dhar S.K., Mukhopadhayay K., Suneet S., Saini P., Mukhopadhayay G., Prasad R. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis. Biochemistry 2003, 42:10822-10832.
20. Rai V., Gaur M., Kumar A., Shukla S., Komath S.S., Prasad R. A novel catalytic mechanism for ATP hydrolysis employed by the N-terminal nucleotide-binding domain of Cdr1p, a multidrug ABC transporter of Candida albicans. Biochim. Biophys. Acta 2008, 1778:2143-2153.
21. Frillingos S., Sahin-Toth M., Wu J., Kaback H.R. Cys-scanning mutagenesis: a novel approach to structure-function relationships in polytopic membrane proteins. FASEB J. 1998, 12:1281-1299.